AABM News Roundup: July 2021 Synchron, a 20-person biotech firm, edged out Elon Musk’s Neuralink to win the FDA’s first approval to start human trials for its brain chip. The early feasibility study of their flagship product, Stentrode, will attempt to give paralyzed patients control over a digital interface using their thoughts only. “Synchron’s north…